Related Experiment Video

Updated: Apr 28, 2026

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

6.5K

¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases

Karlo J Lizarraga1, Antonio A F De Salles, Wei Chen

  • 1Department of Neurology, University of Miami, Miami, FL, USA.

Expert Review of Medical Devices
|June 5, 2014
PubMed

Insights

Fluorine-18-fluorodopa (18F-FDOPA) PET shows promise for diagnosing brain metastases. This imaging technique may improve differentiating tumor recurrence from radiation injury and aid treatment planning.

Area of Science:

  • Neuroimaging
  • Oncology
  • Radiochemistry

Background:

  • Magnetic Resonance Imaging (MRI) is standard for brain metastases but has limitations.
  • Positron Emission Tomography (PET) with 18F-FDOPA offers metabolic insights beyond MRI.
  • Brain metastases pose diagnostic and therapeutic challenges, necessitating advanced imaging modalities.

Discussion:

  • 18F-FDOPA PET can differentiate tumor recurrence from radiation injury, a common clinical dilemma.
  • Semi-quantitative and qualitative PET parameters show diagnostic utility.
  • Kinetic analysis and time-activity curve patterns may enhance diagnostic accuracy.

Key Insights:

  • 18F-FDOPA PET provides prognostic information in brain metastases.
  • Integrating MRI with 18F-FDOPA PET can improve tumor delineation for interventions like biopsy or resection.
  • Metabolic information from 18F-FDOPA PET complements structural MRI data.

Outlook:

  • Further studies are needed to validate 18F-FDOPA PET for treatment monitoring and planning.
  • This technique holds potential to improve diagnostic accuracy and prognosis prediction for brain metastases.
  • 18F-FDOPA PET may become a crucial tool for managing the increasing number of patients with brain metastatic disease.
Keywords:
18F-FDOPAPETbrain metastasesdiagnosistreatment

More Related Videos

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases11:03

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

14.5K
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

9.8K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
850